Clearside Biomedical, Inc.

CLSDQ SEC CIK 1539029
Follow Clearside Biomedical Weekly email: filings, results, news

Financials

Reported figures only · latest: Q3 2025 USD · US GAAP
Revenue, last quarter $201K −80.6% vs same quarter last year
Net income −$6M +22.3% vs same quarter last year
EPS, diluted −$1.14 +26% vs same quarter last year
Operating cash flow −$5.5M +7.3% vs same quarter last year
Revenue by quarter
$6.3M
$230K
$90K
$1M
$306K
$2.3M
$492K
$201K
Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$100M−$50M$0$50MFY14FY16FY18FY20FY22FY24
Show the numbers
YearRevenueNet income
FY24$1.7M−$34.4M
FY23$8.2M−$32.5M
FY22$1.3M−$32.9M
FY21$29.6M$376K
FY20$7.9M−$18.2M
FY19$2.2M−$30.8M
FY18$30K−$82.8M
FY17$345K−$59M
FY16$520K−$25.9M
FY15-−$17.6M
FY14-−$10.2M
FY13--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−300000%−200000%−100000%0%100000%FY14FY16FY18FY20FY22FY24
Show the numbers
YearGross marginOperating marginNet margin
FY2491%−1735.7%−2064.4%
FY2395.7%−302%−394.9%
FY2284.6%−2281.6%−2482.8%
FY21100%−2.1%1.3%
FY20-−227.2%−230.7%
FY19-−1394.6%−1416%
FY18-−276483.3%−276060%
FY17-−16929.9%−17094.2%
FY16-−4845.8%−4977.3%
FY15---
FY14---
FY13---
Free cash flowOperating cash flow minus capital expenditure
−$80M−$60M−$40M−$20M$0FY14FY16FY18FY20FY22FY24
Show the numbers
YearFree cash flow
FY24−$25.7M
FY23−$19.9M
FY22−$13.6M
FY21−$10.7M
FY20−$13.2M
FY19−$27.1M
FY18−$79.3M
FY17−$51.4M
FY16−$22.7M
FY15−$13.9M
FY14−$9.3M
FY13-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Clearside Biomedical
  • Healthcare median
−300000%−200000%−100000%0%100000%FY14FY16FY18FY20FY22FY24
Show the numbers
YearClearside BiomedicalHealthcare median
FY24−2064.4%−60.7%
FY23−394.9%−97.1%
FY22−2482.8%−128.5%
FY211.3%−129.2%
FY20−230.7%−136.5%
FY19−1416%−133.7%
FY18−276060%−173.4%
FY17−17094.2%−176.7%
FY16−4977.3%−164.8%
FY15-−183.4%
FY14-−133%
FY13-−88.5%

News

No stories filed under Clearside Biomedical yet - coverage appears here as the news feed clusters it.